2021 CMSC Annual Meeting

Tag: Biostatistics

Poster-Disease-modifying Therapy

Effect of Age on the Change of Lymphocytes and Immunoglobulins during Treatment with Ocrelizumab or Rituximab for Multiple Sclerosis and Related Disorders

Background: Depletion of B lymphocytes is a known therapeutic strategy for multiple sclerosis (MS) and related disorders. Ocrelizumab (OCR)...

Read More

Poster-Complementary and Alternative Therapies

Mindfulness Based Art Therapy to Improve Symptoms Among Adults with Multiple Sclerosis

Background: Multiple sclerosis (MS) MS affects nearly one million people in the United States and more than two million worldwide. Symptoms...

Read More

Platform-Disease Management

COVID-19 in Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody Disease Patients in North America

Background: The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) raised...

Read More